Thyrotropin-releasing hormone (TRH) increases activity and decreases food intake, body weight, and sleep, in part through hypothalamic actions. The mechanism of this action is unknown. Melanin-concentrating hormone (MCH) and hypocretin/orexin neurons in the lateral hypothalamus (LH) together with neuropeptide Y (NPY) and proopiomelanocortin (POMC) neurons in the arcuate nucleus play central roles in energy homeostasis. Here, we provide electrophysiological evidence from GFP-reporter transgenic mouse brain slices that shows TRH modulates the activity of MCH neurons. Using whole-cell current-clamp recording, we unexpectedly found that TRH and its agonist, montrelin, dose-dependently inhibited MCH neurons. Consistent with previous reports, TRH excited hypocretin/orexin neurons. No effect was observed on arcuate nucleus POMC or NPY neurons. The TRH inhibition of MCH neurons was eliminated by bicuculline and tetrodotoxin, suggesting that the effect was mediated indirectly through synaptic mechanisms. TRH increased spontaneous IPSC frequency without affecting amplitude and had no effect on miniature IPSCs or EPSCs. Immunocytochemistry revealed little interaction between TRH axons and MCH neurons, but showed TRH axons terminating on or near GABA neurons. TRH inhibition of MCH neurons was attenuated by Na ϩ -Ca 2ϩ exchanger (NCX) inhibitors, TRPC channel blockers and the phospholipase C inhibitor U-73122. TRH excited LH GABA neurons, and this was also reduced by NCX inhibitors. Finally, TRH attenuated the excitation of MCH neurons by hypocretin. Together, our data suggest that TRH inhibits MCH neurons by increasing synaptic inhibition from local GABA neurons. Inhibition of MCH neurons may contribute to the TRH-mediated reduction in food intake and sleep.
Introduction
Thyrotropin-releasing hormone (TRH) is a hypothalamic tripeptide hypophysiotropic hormone that was originally isolated as a releasing hormone that stimulated pituitary thyrotropin release and ultimately, thyroxin (Reichlin, 1989) . Subsequently, TRH was also found in axons terminating on hypothalamic neurons, and in other regions of the brain (Lechan and Fekete, 2006) . TRH has an important role in modulating energy homeostasis within the CNS (Lechan and Fekete, 2006) . Central administration of TRH or TRH agonists consistently reduces food intake in normal rodents, hungry rats, and in models of stress-induced feeding (Vijayan and McCann, 1977; Vogel et al., 1979; Morley, 1980; Suzuki et al., 1982; Horita, 1998; Steward et al., 2003) . TRH increases locomotor activity (Wei et al., 1975; Ervin et al., 1981) which also exerts an indirect effect on energy homeostasis (Castañeda et al., 2005) . Additionally, TRH reduces sleep and cataplexy in narcoleptic animals (Nishino et al., 1997) .
Melanin-concentrating hormone (MCH) is a cyclic 19-amino acid peptide (Saito et al., 1999) that is released by MCH neurons in the lateral hypothalamus (LH)/perifornical area which project broadly throughout the brain (Bittencourt et al., 1992) . Acting through its G-protein-coupled receptors MCHR1 and MCHR2 (MCH R2 receptors are found only in humans) (Forray, 2003) , MCH can modulate activity in a large number of brain regions. Intracerebral injection of MCH increases feeding and body weight in rodents (Qu et al., 1996; Rossi et al., 1999) ; MCH mRNA expression is increased by fasting in normal rats or hypoleptinemic ob/ob mice (Presse et al., 1996; Qu et al., 1996) . MCH analogs increase food intake (Suply et al., 2001 ) and chronic intracerebroventricular infusion of synthetic MCHR1 agonists induces obesity (Della-Zuana et al., 2002; Ito et al., 2003) . Conversely, MCHR1 antagonists decrease food intake and body weight in both normal and diet-induced obese rats (Borowsky et al., 2002) . These observations underline the essential role of MCH in modulating energy homeostasis. In addition, MCH cells play a role in the sleep-wake cycle. MCH neurons are sleep-active, but are quiet during periods of wakefulness (Verret et al., 2003; Hassani et al., 2009; Hassani et al., 2010) . MCH agonists increase sleep (Lagos et al., 2009 ) whereas MCH antagonists reduce sleep (Ahnaou et al., 2008) . MCH neurons are anatomically coextensive with neurons that synthesize hypocretin/orexin (Hcrt), which are wake-active and have been implicated in energy homeostasis and cognitive arousal (Sakurai et al., 1998; Lee et al., 2005) . Recent reports showed a direct excitatory action of TRH on hypocretin neurons (González et al., 2009; Hara et al., 2009 ).
To address the question of how TRH might influence hypothalamic neurons posited to modulate energy homeostasis, we investigated the effects of TRH on hypothalamic neurons that synthesize MCH, Hcrt, proopiomelanocortin (POMC), neuropeptide Y (NPY), or GABA using whole-cell patch-clamp recording in brain slices from a series of transgenic mice that express GFP in transmitter-select groups of neurons.
Materials and Methods
Brain slice preparation. To identify the correct cells from which to record, we used transgenic mice that express a GFP reporter in select neurons. The transgenic mice used included MCH-GFP (van den Pol et al., 2004) , hypocretin-GFP (Li et al., 2002) , glutamate decarboxylase 67-GFP (GAD-GFP) (Acuna-Goycolea et al., 2005) , POMC-GFP (Cowley et al., 2001 ) and NPY-GFP (van den Pol et al., 2009 ). Male and female mice aged 14 -49 d old were used. Mice were housed in a climate-controlled environment at a temperature of 22°C with a 12 h light/dark cycle and ad libitum access to food and water. On the day of the experiment, mice were anesthetized with Nembutal (100 mg/kg) and decapitated. Brains were quickly removed and immersed in ice-cold high-sucrose solution containing (in mM): 220 sucrose, 2.5 KCl, 6 MgCl 2 , 1 CaCl 2 , 1.23 NaH 2 PO 4 , 26 NaHCO 3 , 10 glucose and gassed with 95% O 2 /5% CO 2 ; pH 7.4 with NaOH, 300 -305 mOsm). Coronal brain slices (300 m thick) were prepared using a vibratome to cut slices containing the hypothalamus. Slices were transferred to an incubation chamber filled with artificial CSF (ACSF) solution containing (in mM): 124 NaCl, 2.5 KCl, 2 MgCl 2 , 2 CaCl 2 , 1.23 NaH 2 PO 4 , 26 NaHCO 3 , and 10 glucose (gassed with 95% O 2 /5% CO 2 ; pH 7.4 with NaOH, 300 -305 mOsm), and stored at room temperature (22°C). After a 1-2 h recovery period, slices were transferred to a recording chamber mounted on a BX51WI upright microscope (Olympus). Slices were perfused with a continuous flow of gassed ACSF. Experiments were performed at 33 Ϯ 1°C using a dual-channel heat controller (Warner Instruments). All procedures in this study were ap- segments of the trace (bottom). RMP, Ϫ59 mV. C, Representative trace showing no obvious effect of TRH (1 M) on membrane potential or spike frequency of a POMC neuron. RMP, Ϫ58 mV. D, Representative trace showing no obvious effect of TRH (1 M) on membrane potential or firing rate of an NPY neuron. RMP, Ϫ54 mV. E, Bar graph showing the reversible hyperpolarization of the membrane potential of MCH neurons (n ϭ 15), but reversible depolarization of Hcrt neurons (n ϭ 6) by application of TRH (1 M). No significant effect was observed on membrane potential of POMC (n ϭ 14) or NPY neurons (n ϭ 12). F, Summary of data showing TRH (1 M) reversibly decreases spike frequency of MCH neurons (n ϭ 6) but increases spike frequency of Hcrt neurons (n ϭ 6). The spike frequency of POMC (n ϭ 14) or NPY (n ϭ 12) neurons was not changed by TRH (1 M). *p Ͻ 0.05, **p Ͻ 0.01 compared with control, paired t tests. Error bars indicate SEM.
proved by the Yale University Committee on Animal Care and Use.
Patch-clamp recording. Whole-cell patch recordings were performed on GFP-expressing neurons that were visualized with a GFP filter set and an infrared-differential interference contrast optical system combined with a monochrome CCD camera and a monitor. Pipettes used for whole-cell recording were pulled from thin-walled borosilicate glass capillary tubes (length 75 mm, outer diameter 1.5 mm, inner diameter 1.1 mm, World Precision Instruments) using a P-97 Flaming/Brown micropipette puller (Sutter Instruments) and had resistances ranging from 4 to 6 M⍀ when filled with pipette solution containing (in mM): 145 K-gluconate (or KCl for IPSCs), 1 MgCl 2 , 10 HEPES, 1.1 EGTA, 2 Mg-ATP, 0.5 Na 2 -GTP, 5 Na 2 -phosphocreatine, pH 7.3 with KOH (290 -295 mOsm). Pipettes were connected via an Ag-AgCl wire to the headstage of an EPC-10 patch-clamp amplifier (HEKA Instruments). The reference electrode was an Ag-AgCl pellet (IVM) immersed in the bath solution. Pipette and cell capacitance were compensated for using PatchMaster 2.20 software (HEKA Elektronik). Neurons in which the series resistance was Ͼ20 M⍀ and changed Ͼ15% were excluded from the statistics. PatchMaster 2.20 was used to acquire and analyze the data. Traces were processed using Igor Pro carbon 4.07 (WaveMetrics). Spontaneous and miniature postsynaptic currents were analyzed with MiniAnalysis 6.03 (Synaptosoft Inc.).
Immunocytochemistry. To determine whether TRH might be released by axon terminals near GABA or MCH neurons in the LH, we combined immunocytochemistry with detection of GFP in GAD-GFP or MCH-GFP mice. Briefly, transgenic GFP-positive mice were anesthetized with sodium pentobarbital, and then perfused transcardially with saline followed by 4% paraformaldehyde. Sixteen micron thick coronal sections were cut on a cryostat, immersed in normal PBS for 15 min and then treated with 2% normal horse serum in PBS for 30 min, and then incubated overnight at 4°C in polyclonal rabbit anti-TRH antiserum (1:5000, kind gift from Dr T. Visser, Erasmus University Medical School, Rotterdam, The Netherlands) and described in detail previously (Klootwijk et al., 1995; González et al., 2009; Lyons et al., 2010) . After washing 3 ϫ 10 min in PBS, sections were placed in secondary antisera of Alexa594 don- key anti-rabbit IgG at a dilution of 1:200 for 30 min, washed, and mounted on glass slides. Sections were studied on an Olympus IX70 inverted fluorescence microscope. Micrographs were recorded with a Spot digital camera (Diagnostic Imaging), and contrast and brightness were corrected using Photoshop CS4.
Statistical analysis. Data are expressed as mean Ϯ SEM. Group statistical significance was assessed using Student's t test for comparison of two groups, and one-way ANOVA followed by a Bonferroni post hoc test for three or more groups. p Ͻ 0.05 was considered statistically significant.
Drugs and drug application. TRH (human, rat, mouse), and hypocretin-2 (mouse, rat, porcine) were purchased from Phoenix Pharmaceuticals. Montirelin trifluoroacetate salt (montirelin) and U-73122 hydrate were from Sigma-Aldrich. Tetrodotoxin (TTX), bicuculline (Bic), 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), DL-2-amino-5-phosphonopentanoic acid (D-AP5), SN-6, SKF96365, 2-APB, and KB-R7943 mesylate were obtained from Tocris Bioscience. All drugs were prepared and stored as stock solutions according to the manufacturer's instructions, and diluted in ACSF to obtain the experimental concentration for application before each experiment. All drug solutions were given by large diameter (500 m) flow pipe with the tip directed toward the recorded cell. During periods of no drug application, normal ACSF was continuously supplied to the recorded cell through the flow pipe.
Results

TRH exerts opposite actions on MCH and hypocretin neurons
Using whole-cell patch-clamp recording, we first examined the effects of TRH on MCH neurons in the LH/perifornical area. In current clamp, most MCH neurons were silent and the application of TRH (1 M) reversibly hyperpolarized the membrane potential from Ϫ59.0 Ϯ 0.8 mV to Ϫ64.1 Ϯ 1.0 mV and the membrane potential recovered to Ϫ60.6 Ϯ 1.2 mV after peptide washout ( Fig. 1 A, E, n ϭ 15, p Ͻ 0.01, paired t test). More than 80% (15 of 18) of MCH cells tested responded to 1 M TRH by hyperpolarization. Not all MCH neurons showed spontaneous spikes, but in those that did, TRH (1 M) decreased spike frequency from 1.0 Ϯ 0.2 Hz to 0.3 Ϯ 0.2 Hz (Fig. 1 A, F , n ϭ 6, p Ͻ 0.05, paired t test); spikes recovered to 0.9 Ϯ 0.2 Hz after peptide washout. Because TRH has generally been associated with excitatory actions, the TRH-mediated inhibition identified here was unexpected. As a control, we next recorded from nearby Hcrt neurons which were recently shown to be excited by TRH (González et al., 2009; Hara et al., 2009) . Consistent with previous reports, TRH (1 M) excited the Hcrt neurons ( Fig. 1 B) , depolarizing the membrane potential from Ϫ58.4 Ϯ 1.5 mV to Ϫ51.3 Ϯ 1.6 mV ( Fig. 1 E, n ϭ 6, p Ͻ 0.01, paired t test) and increasing the spike frequency from 2.6 Ϯ 0.8 Hz to 8.2 Ϯ 0.9 Hz ( Fig. 1 F, n ϭ 6, p Ͻ 0.01, paired t test). These results indicate that TRH may modulate MCH neurons through a different mechanism than for Hcrt neurons.
Similar to MCH neurons, some cells in the hypothalamic arcuate nucleus-primarily orexigenic NPY neurons and anorexigenic POMC cells-are involved in energy homeostasis. We therefore tested whether TRH might modulate the activity of POMC and NPY neurons. TRH (1 M) had no apparent effect on the membrane potential of POMC neurons (pre-TRH: Ϫ53.9 Ϯ 0.8 mV; in TRH: Ϫ53.7 Ϯ 0.9 mV) (Fig. 1C ,E, n ϭ 14, p Ͼ 0.05, paired t test) or spike frequency (pre-TRH: 1.9 Ϯ 0.4 Hz; in TRH: 2.1 Ϯ 0.4 Hz (Fig. 1C,F , n ϭ 14, p Ͼ 0.05, paired t test). Similarly, no obvious effect of TRH was observed on the activity of NPY neurons. Application of TRH (1 M) did not influence the membrane potential of NPY neurons (pre-TRH Ϫ55.6 Ϯ 1.2 mV; in TRH Ϫ55.4 Ϯ 1.1 mV) ( Fig. 1 D, E , n ϭ 12, p Ͼ 0.05, paired t test) or spike frequency (pre-TRH: 1.4 Ϯ 0.2 Hz; in TRH:
TRH selectively increases GABA release onto MCH neurons MCH neurons are innervated primarily by GABA neurons, and this presynaptic GABAergic input may play a principal role in subserving neuronal communication to the MCH cell (van den Pol et al., 2004; Li and van den Pol, 2009) . MCH cells express a number of GABA receptors, including GABA A R ␣1 (Harthoorn et al., 2005) , ␣2, ␣3 (Bäckberg et al., 2004) and (Moragues et al., 2003) . To investigate the mechanism underlying the TRH inhibition of MCH neurons described above, we examined the effect of TRH on spontaneous IPSCs (sIPSCs) of MCH neurons. In the presence of D-AP5 (50 M) and CNQX (10 M) to eliminate spontaneous EPSCs (sEPSCs), we recorded sIPSCs that were completely blocked by the GABA A receptor antagonist bicuculline (Bic ϭ 30 M; Fig. 2A ). TRH (1 M) significantly increased the IPSC frequency to 423 Ϯ 115% of control (Fig. 2 A, B , n ϭ 6, p Ͻ 0.01, paired t test); the amplitude remained unaltered (128 Ϯ 18% of control, Fig. 2 A, C, n ϭ 6, 
TRH inhibition of MCH neurons is completely antagonized by blocking GABAergic inputs
Our experiments above were performed on MCH neurons from brain slices of young mice (postnatal day 14 -21); we therefore tested whether TRH produces similar effects on MCH neurons from brain slices of adult mice (postnatal day 42-49). TRH (1 M) hyperpolarized the membrane potential by 4.6 Ϯ 0.5 mV (n ϭ 6) a magnitude of effect not statistically different from the value obtained using young mice (5.1 Ϯ 0.6 mV, n ϭ 15). We also recorded the effects of different concentrations of TRH on MCH neurons using doses ranging from 3 nM to 1 M and found that TRH hyperpolarized MCH neurons in a dose-dependent manner (Fig. 3B , n ϭ 55 cells). We next tested whether TRH inhibits MCH neurons by a mechanism based on increased GABAergic inhibition through GABA release from presynaptic neurons. In the presence of Bic (30 M) to block all GABA A receptor-mediated inhibition, TRH (1 M) failed to hyperpolarize the membrane potential of MCH neurons (0.1 Ϯ 0.2 mV change, n ϭ 7, Fig. 3 A, C) .
In the presence of TTX (0.5 M) to block transmitter release mediated by the excitation of presynaptic neurons, we tested the effect of TRH on the membrane potential of MCH neurons and found TRH (1 M) exerted no effect on MCH neurons (membrane potential changed by 0.1 Ϯ 0.2 mV, n ϭ 7, Fig. 3 A, C) . This result together with Bic blockade of TRH inhibition indicates that TRH inhibits MCH neurons through excitation of GABA neurons presynaptic to MCH cells.
Lack of TRH effect on miniature IPSCs
We next tested the effect of TRH on miniature IPSCs (mIPSCs) in the presence of TTX (0.5 M) to block spikes, and D-AP5 (50 M) and CNQX (10 M) to block glutamate receptor responses. As shown in Figure 4 , neither the frequency nor the amplitude of mIPSCs was affected by TRH (1 M). These results suggest that TRH does not inhibit MCH neurons by acting on the axon terminals of presynaptic GABA neurons, but instead acts on GABAergic cell bodies/dendrites.
TRH excites neighboring GABA neurons in LH
To ascertain whether TRH excites neighboring GABA neurons in the LH/perifornical area, we performed whole-cell patch recording on GAD-GFP neurons (n ϭ 14) in this region. Seven of 14 neurons were strongly excited by TRH (Fig. 5A) . TRH (1 M) significantly depolarized the membrane potential from Ϫ60.2 Ϯ 1.7 mV to Ϫ54.4 Ϯ 1.6 mV (Fig. 5 B, C , n ϭ 7, p Ͻ 0.05, paired t test) and increased the spike frequency from 0.5 Ϯ 0.2 Hz to 3.9 Ϯ 1.2 Hz (Fig. 5 B, D , n ϭ 7, p Ͻ 0.01, paired t test). Additionally, we found that TRH inhibited 3 of 14 neurons, and had no obvious effect on another 4 neurons (Fig. 5A) . To rule out the possibility that the TRH-mediated membrane potential change is random during recording with time, we compared the absolute change in membrane potential after 30 s treatment of ACSF or TRH. The absolute change of membrane potential found in control ACSF over 30 s was 0.5 Ϯ 0.1 mV. In contrast, after 30 s treatment of TRH (1 M), the absolute value of the membrane potential change was significantly altered by 4.1 Ϯ 1.0 mV (Fig. 5A , n ϭ 14, p Ͻ 0.01, paired t test), confirming an action of TRH on the GABA neurons taken as an entire group (n ϭ 14). The different response of GAD-GFP neurons to TRH suggests a diversity of GABA neuron responses in the LH. Based on reports that GAD and MCH are coexpressed in some MCH neurons (Elias et al., 2001) , this result together with the TRH inhibition of MCH neurons raises the possibility that GAD-GFP neurons with an inhibitory response to TRH might be MCH neurons, or that other GABA neurons are inhibited by TRH indirectly in the same manner that MCH cells are. Thus, TRH excitation of the GABA neurons in this region is consistent with the view that TRH increases GABA release onto MCH neurons in the LH.
To confirm that TRH directly activates GABA neurons in the LH, we examined the effect of TRH (1 M) on membrane poten- tial of GABA neurons in the presence of TTX (0.5 M). In 8 of 13 cells, TRH (1 M) significantly depolarized the membrane potential from Ϫ60.3 Ϯ 1.7 mV to Ϫ54.7 Ϯ 2.0 mV (Fig. 5 E, F , n ϭ 8, p Ͻ 0.05, paired t test). This result confirms that TRH directly activates GABA neurons. None of the 13 cells tested showed any TRH-mediated hyperpolarization in the presence of TTX (0.5 M), suggesting the hyperpolarization effect by TRH found in the absence of TTX is through an indirect mechanism.
TRH inhibits MCH neurons by activating TRH receptor-related signaling pathway
Previous studies have shown that activation of TRH receptors excites neurons in other brain regions by activating phospholipase C (PLC) (Ishibashi et al., 2009 ) and the Na ϩ -Ca 2ϩ exchanger (NCX) (Parmentier et al., 2009 ). Therefore, we tested the effects of antagonists of PLC and the NCX on TRH inhibition of MCH neurons. First, we recorded the effect of montirelin, an agonist of the TRH receptor (Parmentier et al., 2009 ). Montirelin (3 M) mimicked the effect of TRH and hyperpolarized the membrane potential by 3.1 Ϯ 0.8 mV (Fig. 6 B, n ϭ 6) .
To test whether PLC is involved in the inhibitory effect of TRH on MCH neurons, we measured the effect of TRH on the membrane potential of MCH neurons in the presence of U-73122, a PLC inhibitor. Application of TRH (1 M) in the presence of U-73122 (0.5 M) yielded an alteration in membrane potential of only 0.1 Ϯ 0.8 mV (Fig. 6 B, n ϭ 7) indicating TRH actions to inhibit MCH neurons were blocked under these conditions. Next, we tested whether NCX is involved in the TRH inhibition of MCH neurons using KB-R7943 (60 M), a nonselective NCX blocker. In the presence of KB-R7943, TRH (1 M) had no effect on membrane potential (0.0 Ϯ 0.4 mV) (Fig.  6 B, n ϭ 8) , indicating there was no hyperpolarization by TRH. KB-R7943 has been reported to block TRPC channels at this concentration (Kraft, 2007 ). Therefore, we tested the effect of SN-6, a NCX blocker reported to be more selective than KB-R7943 (Niu et al., 2007) . In the presence of SN-6 (10 M), the TRH-induced hyperpolarization was attenuated to 2.1 Ϯ 0.4 mV (Fig. 6 B, n ϭ 6) , suggesting that the NCX was responsible for part of the response, but that other mechanisms were also involved. TRPC channels have been suggested to be downstream of PLC in other hypothalamic neurons such as POMC cells (Qiu et al., 2010) . To examine whether the TRPC channel is also involved in TRH inhibition of MCH neurons, we measured the TRH effect on MCH neuron membrane potential in the presence of the TRPC channel blockers 2-APB or SKF96365. Extracellular 2-APB (100 M) reduced TRH-induced hyperpolarization of MCH neurons to 2.9 Ϯ 0.5 mV (Fig. 6 B, n ϭ 7) , suggesting that TRPC channels contribute to TRH inhibition of MCH neurons. To further confirm this, we examined the effect of SKF96365, another potent TRPC channel blocker. In the presence of SKF96365 (30 M), TRH-induced hyperpolarization of MCH neurons was attenuated to 2.5 Ϯ 0.4 mV (Fig. 6 B, n ϭ 10) . Together, these results suggest that both NCX and TRPC channels, which are located downstream of PLC, contribute to the TRH inhibition of MCH neurons.
Mechanism for TRH activation of LH GAD-GFP neurons
To further confirm the mechanisms underlying the TRH effect revealed by the study of MCH neurons described above, we performed parallel experiments to test GAD-GFP neurons directly. In the presence of TTX (0.5 M), D-AP5 (50 M), CNQX (10 M) and Bic (30 M), TRH (1 M) evoked an obvious inward current with a mean value of 9.8 Ϯ 1.9 pA (Fig. 7 A, B, n ϭ 10) . When U-73122 (0.5 M), KB-R7943 (60 M), SN-6 (10 M) or SKF96365 were applied in the bath solution, the current was inhibited to 1.9 Ϯ 1.2 pA (n ϭ 6), 1.8 Ϯ 1.0 pA (n ϭ 7), 3.5 Ϯ 1.5 pA (n ϭ 9) and 4.6 Ϯ 1.0 pA (n ϭ 9) respectively (Fig. 7 A, B) . These results indicated that the TRH-induced current was almost completely inhibited by U-73122 (0.5 M), indicating that PLC contributes to TRH activation of GABA neurons. In addition, TRH-activated current was almost completely inhibited by KB-R7943 (60 M) and partially inhibited by SN-6 (10 M) or SKF96365 (30 M), further confirming that both NCX and TRPC channels were involved in TRH activation of GABA. To further address the underlying mechanism of TRH action on GABA neurons, we next used voltage ramps. The TRH-evoked currents were tested using a ramp voltage protocol from Ϫ130 to Ϫ20 mV starting from a holding potential of Ϫ60 mV. With the perfusion of normal ACSF with TTX (0.5 M), D-AP5 (50 M), CNQX (10 M), Bic (30 M) and Cd 2ϩ (200 M), using K-gluconate in the pipette solution, the ramp induced a current response as shown in Figure 7C ; TRH (1 M) increased the current evoked by this ramp protocol. After subtracting the current of the control from that of TRH, a TRH-evoked current was obtained (Fig. 7D) . The reversal potential was Ϫ26 Ϯ 2 mV (n ϭ 4), consistent with TRH activation of both NCX and TRPC channels.
We next investigated the current-voltage relationship before and after applying TRH (1 M) by injecting a series of square wave currents from Ϫ80 to 0 pA. The input resistance was calculated based on the linear part of the current-voltage relationship curve (Fig. 7E1-E3 ). TRH (1 M) reduced the input resistance from 717.9 Ϯ 15.1 M⍀ to 617.7 Ϯ 9.8 M⍀ ( p Ͻ 0.05, n ϭ 5, paired t test). These results confirm that TRH not only activates NCX as demonstrated by the above results, but also directly opens ion channels on GABA neurons which would lead to a reduction in input resistance, consistent with the opening of TRPC channels.
TRH attenuates hypocretin excitation of MCH neurons
Hypocretin axons directly innervate MCH neurons (Guan et al., 2002; van den Pol et al., 2004) and the hypocretin peptide (hypocretin-2, Hcrt-2) excites MCH cells (van den Pol et al., 2004) . We asked whether TRH antagonizes the Hcrt-induced excitation of MCH neurons through an increase of GABA inhibition. In one group of MCH neurons, Hcrt-2 (1 M) depolarized the membrane potential of MCH neurons by 3.3 Ϯ 0.9 mV after 1 min and 4.2 Ϯ 1.1 mV after a 2 min exposure (Fig. 8 A, C, n ϭ 7) . No significant difference was found in the level of depolarization between 1 and 2 min of Hcrt-2 treatment. In another group of neurons, Hcrt-2 (1 M) produced a similar level of depolarization (3.6 Ϯ 0.9 mV) at 1 min after treatment. In the second minute, we added TRH (1 M) to the Hcrt-2 (1 M) solution. TRH addition antagonized the Hcrt-induced depolarization and Hcrt evoked only a 0.3 Ϯ 0.8 mV change in the presence of TRH ( p Ͻ 0.05 compared with the 3.6 mV depolarization evoked by Hcrt with no TRH, n ϭ 11, Fig. 8 A, C) . In MCH neurons that showed action potentials, Hcrt-2 (1 M) increased the spike frequency from 0.7 Ϯ 0.3 Hz to 3.0 Ϯ 1.2 Hz ( p Ͻ 0.05, n ϭ 5, Fig.  8 B, D) . TRH (1 M) addition to Hcrt-2 (1 M) attenuated the increase in spike frequency (1.0 Ϯ 0.5 Hz; n ϭ 5; p Ͻ 0.05 compared with 3 Hz with Hcrt alone; Fig. 8 B, C) . Together, these Figure 6 . TRH hyperpolarizes MCH neurons through activation of the TRH receptor and its downstream signaling pathway. A, Representative traces showing TRH (1 M; RMP, Ϫ59 mV) and montirelin (3 M; RMP, Ϫ61 mV), a TRH receptor agonist, both hyperpolarize MCH neurons. U-73122 (0.5 M; RMP, Ϫ54 mV) and KB-R7943 (60 M; RMP, Ϫ60 mV) both block TRH-mediated hyperpolarization. SN-6 (10 M; RMP, Ϫ59 mV), 2-APB (100 M; RMP, Ϫ59 mV) and SKF96365 (30 M; RMP, Ϫ59 mV) attenuate TRH-mediated hyperpolarization. B, Summary of data showing montirelin (n ϭ 6) mimics the hyperpolarization effect of TRH (n ϭ 13), whereas U-73122 (n ϭ 7) and KB-R7943 (n ϭ 8) block the TRH effect on MCH neurons. SN-6 (n ϭ 6), 2-APB (n ϭ 7) and SKF96365 (n ϭ 10) all attenuate the TRH effect on MCH neurons. *p Ͻ 0.05 and **p Ͻ 0.01 versus TRH effect without antagonists.
results indicate that TRH antagonized the hypocretin excitation of MCH neurons.
TRH axons abut GABA cells, but not MCH cells TRH axons were immunostained red with Alexa 594. As reported previously (Nishiyama et al., 1985) , TRH-immunoreactive axons are found in many regions of the medial hypothalamus, with a particularly high density in the dorsomedial nucleus. In addition, there are regions of the LH that also contain relatively high densities of immunoreactive axons, and other regions of the LH with relatively few immunoreactive axons. In general there was a medial to lateral decrease in the density of TRHimmunoreactive axons, with the fewest axons and boutons found in the most lateral region of the LH (Figs. 9, 10 D) . Although a small number of errant TRHimmunoreactive axons trespassed near MCH cells, particularly in the most medial MCH neurons, we found little overlap between green MCH cells visualized by GFP expression in sections from MCH-GFP transgenic mice, and red TRH axons (Figs. 9, 10C ). This is consistent with the lack of direct response of MCH cells to TRH, described above. In contrast, when we examined sections from a GAD-GFP mouse, we found a high frequency of appositions between red immunoreactive TRH axons and green GABA cells (Fig.  10A,B) in some, but not all, regions of the LH. A semiquantitative analysis of TRHimmunoreactive bouton density showed a higher density in LH/perifornical regions rich in GAD-GFP cells, and fewer in regions of high MCH cell density (Fig. 10D) .
Discussion
In the present study, we found that TRH produced an unexpected inhibitory action on MCH neurons. Using whole-cell recording, we showed an indirect hyperpolarizing action of TRH on MCH neurons that was blocked by TTX and the GABA A receptor antagonist bicuculline. TRH strongly activated presynaptic GABA neurons and increased GABA release onto MCH neurons. TRH-immunoreactive axons terminated on or near GABA (GAD-GFP) neurons in the LH, but not on MCH cells. The inhibitory effect of TRH recorded in MCH neurons was mimicked by the TRH agonist montirelin and blocked by antagonists of PLC, NCX and TRPC. In parallel, TRH activation of GABA neurons was inhibited by antagonists of PLC, NCX and TRPC, further confirming the involvement of an intracellular signaling pathway from TRH receptor to downstream PLC activation that opened TRPC channels and activated the NCX. Together, these results demonstrate that TRH inhibits MCH neurons indirectly by increasing GABAergic inhibition.
Mechanisms for TRH action
The primary synaptic input to MCH neurons in the LH is GABAergic, underlining the strong contribution of inhibitory signaling here (van den Pol et al., 2004; Li and van den Pol, 2009 ). Thus, functional modulation targeting presynaptic GABA neurons may have a high impact on the activity of MCH neurons. Immunoreactive TRH fibers and synaptic boutons have been described in the LH (Lechan and Jackson, 1982; Nishiyama et al., 1985; Lechan et al., 1986; González et al., 2009) . Our immunocytochemistry results show that TRH-immunoreactive axons terminate on or near GABA cells in the LH and dorsomedial nucleus; in contrast, relatively few TRH axons are found near MCH cells or dendrites. TRH strongly excited a subpopulation of GABA neurons in the LH. MCH neurons have been reported to be GABAergic because GAD and MCH are coexpressed in some MCH neurons (Elias et al., 2001 ). We found no excitatory effect of TRH on MCH neurons, suggesting that TRH excites specific GABA neurons other than those coexpressing GAD and MCH. TRH increased sIPSC frequency without affecting miniature IPSC frequency, similar to reports in Hcrt neurons (Hara et al., 2009 ). These findings suggest that TRH activates a subpopulation of GABA neurons to increase GABA release onto MCH neurons; we found no evidence for TRH actions on presynaptic axon terminals contacting MCH cells. The view that a GABA neuron in the LH is responsible for producing the TRH inhibition of MCH neurons is supported by the evidence that TRH inhibition was blocked by the GABA A receptor antagonist bicuculline and by blocking spike-dependent transmitter release with TTX. Since the TRH effect did not appear to be mediated directly at the presynaptic terminal, but rather on cell bodies, the cell bodies were most likely neighboring GABA cells in the same brain slice. If the GABA cells were far away, it is likely that the axons would have been severed during slice preparation. An additional possibility is that GABA neurons in the dorsomedial hypothalamic nucleus that receive TRH innervation, and are potentially contained in the same brain slice as the recorded cell, might contribute to this indirect effect.
TRH-inhibitory effects on MCH neurons were mimicked by the TRH analog montirelin, confirming activation of TRH receptors. The TRH-mediated excitation of local GABA neurons was blocked by U-73122, suggesting a phospholipase C-dependent excitation. TRH actions were also blocked by KB-R7943 and attenuated by SN-6, 2-APB and SKF96365 suggesting a mechanism based on an activation of both NCX and TRPC channels. In contrast to the mechanisms we identified in MCH and GABA cells, TRH excited Hcrt neurons through a Na ϩ -dependent depolarization and activation of a mixed cation current (González et al., 2009 ). Similar to GABA neurons in the LH, TRH was reported to excite posterior hypothalamic histamine neurons through multiple mechanisms (Parmentier et al., 2009) .
Functional relevance to energy homeostasis and arousal TRH plays a role in a variety of biological hypothalamic functions (Lechan and Fekete, 2006) including feeding and metabolism. Central administration of TRH or TRH analogs reduces food intake within 30 min of application (Vijayan and McCann, 1977; Vogel et al., 1979; Morley, 1980; Suzuki et al., 1982; Horita, 1998; Steward et al., 2003) , suggesting an involvement of TRH circuits in the inhibition of food intake and reduction of body weight. Our present study indicates that TRH strongly inhibits MCH neuronal activity. We also corroborate earlier reports that TRH excites Hcrt neurons (González et al., 2009; Hara et al., 2009 and could potentially respond to TRH. However, we found no detectable effect of TRH on POMC or NPY neurons using the same concentration of TRH that excited Hcrt cells and inhibited MCH cells. Both NPY and POMC cells project to paraventricular nucleus (PVN) TRH cells (Légrádi and Lechan, 1998) . Furthermore, leptin increases TRH synthesis and release by directly activating leptin receptors on TRH cells in the PVN (Elmquist et al., 1998; Nillni et al., 2000) and indirectly by activating leptin receptor-expressing POMC neurons in the arcuate nucleus that in turn release ␣-MSH to stimulate TRH neurons expressing the MC4 receptor (Perello et al., 2006) . NPY inhibits TRH synthesis in the PVN through activation of NPY receptors on TRH neurons (Légrádi and Lechan, 1998; Fekete et al., 2000 Fekete et al., , 2001 . Thus, although the POMC and NPY cells may not respond directly to TRH, both cell types still may modulate TRH release. MCH neurons may play a crucial role in signaling downstream from the leptin receptor (Segal-Lieberman et al., 2003) . The hypocretin cell has been suggested to play an orexigenic role in energy homeostasis (Sakurai et al., 1998) ; since TRH excited the presumptive orexigenic hypocretin cell, it is unlikely that the TRH-mediated reduction in food intake is through TRH actions on the hypocretin cell. Together with the apparent lack of effect of TRH on POMC and NPY neurons, and the excitatory actions on hypocretin neurons, MCH neurons might be one primary hypothalamic target for a TRH-mediated decrease of food intake and body weight, mediated by local GABAergic neurons excited by TRH.
Although sleep-wake cycles and food intake in some contexts may seem unrelated, a primary role for sleep may be conservation of energy. Hcrt excites MCH neurons (van den Pol et al., 2004 ); here we found that TRH attenuates this excitation. This would be consistent with a model of TRHinduced arousal mediated by multiple parallel circuits, including direct activation of the arousal hypocretin neurons (González et al., 2009; Hara et al., 2009) , which is complemented by inhibition of pro-sleep MCH neurons (present study), and a further attenuation of hypocretinmediated excitation of MCH cells (present study). Together, these multiple sites of TRH action enhance the differential response of the two opposing [MCH and hypocretin] systems. regions of the hypothalamus, including in areas of high density MCH neurons, high density GAD-GFP neurons, the far lateral (Lat.) LH, the dorsomedial nucleus of the hypothalamus (DMH), and the arcuate nucleus (ARC). Bouton density was determined by counting TRH-immunoreactive boutons in a rectangle measuring 100 ϫ 60 m superimposed over the histological section, using 25 different fields on multiple sections for each of the five regions. The y-axis shows mean bouton density/area measured. Flags on bars represent SEM.
